Plimoth Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.1M | Sell |
18,845
-462
| -2% | -$102K | 0.92% | 36 |
|
|
2025
Q4 | $4.41M | Sell |
19,307
-210
| -1% | -$47.8K | 0.98% | 30 |
|
|
2025
Q3 | $4.52M | Sell |
19,517
-548
| -3% | -$112K | 1.02% | 28 |
|
|
2025
Q2 | $3.72M | Sell |
20,065
-208
| -1% | -$38.7K | 0.89% | 33 |
|
|
2025
Q1 | $4.25M | Sell |
20,273
-22
| -0.1% | -$4.28K | 1.11% | 27 |
|
|
2024
Q4 | $3.61M | Sell |
20,295
-265
| -1% | -$48.7K | 0.93% | 34 |
|
|
2024
Q3 | $4.06M | Sell |
20,560
-1,081
| -5% | -$202K | 1.02% | 30 |
|
|
2024
Q2 | $3.71M | Sell |
21,641
-4,664
| -18% | -$773K | 0.99% | 34 |
|
|
2024
Q1 | $4.79M | Sell |
26,305
-1,987
| -7% | -$342K | 1.28% | 21 |
|
|
2023
Q4 | $4.38M | Sell |
28,292
-524
| -2% | -$76.4K | 1.27% | 22 |
|
|
2023
Q3 | $4.3M | Sell |
28,816
-434
| -1% | -$63.7K | 1.35% | 20 |
|
|
2023
Q2 | $3.94M | Buy |
29,250
+129
| +0.4% | +$18.9K | 1.18% | 21 |
|
|
2023
Q1 | $4.64M | Buy |
29,121
+712
| +3% | +$109K | 1.44% | 19 |
|
|
2022
Q4 | $4.59M | Sell |
28,409
-1,092
| -4% | -$167K | 1.48% | 16 |
|
|
2022
Q3 | $3.96M | Buy |
29,501
+54
| +0.2% | +$7.75K | 1.37% | 16 |
|
|
2022
Q2 | $4.51M | Sell |
29,447
-1,328
| -4% | -$203K | 1.42% | 16 |
|
|
2022
Q1 | $4.99M | Sell |
30,775
-235
| -0.8% | -$34.1K | 1.33% | 18 |
|
|
2021
Q4 | $4.2M | Buy |
31,010
+547
| +2% | +$64.6K | 1.06% | 26 |
|
|
2021
Q3 | $3.29M | Buy |
30,463
+1,032
| +4% | +$118K | 0.93% | 31 |
|
|
2021
Q2 | $3.31M | Sell |
29,431
-1,605
| -5% | -$181K | 0.93% | 32 |
|
|
2021
Q1 | $3.36M | Buy |
31,036
+1,137
| +4% | +$122K | 0.99% | 31 |
|
|
2020
Q4 | $3.2M | Sell |
29,899
-492
| -2% | -$47.3K | 1% | 33 |
|
|
2020
Q3 | $2.66M | Sell |
30,391
-984
| -3% | -$92.6K | 0.89% | 40 |
|
|
2020
Q2 | $3.08M | Sell |
31,375
-850
| -3% | -$74.8K | 1.1% | 24 |
|
|
2020
Q1 | $2.46M | Sell |
32,225
-3,538
| -10% | -$301K | 1.03% | 26 |
|
|
2019
Q4 | $3.17M | Sell |
35,763
-520
| -1% | -$43.2K | 1.02% | 26 |
|
|
2019
Q3 | $2.75M | Sell |
36,283
-4,204
| -10% | -$288K | 0.9% | 30 |
|
|
2019
Q2 | $2.94M | Sell |
40,487
-2,769
| -6% | -$218K | 0.97% | 28 |
|
|
2019
Q1 | $3.49M | Buy |
43,256
+3,980
| +10% | +$326K | 1.16% | 22 |
|
|
2018
Q4 | $3.62M | Buy |
39,276
+481
| +1% | +$42.3K | 1.34% | 17 |
|
|
2018
Q3 | $3.67M | Buy |
38,795
+4,506
| +13% | +$427K | 1.19% | 22 |
|
|
2018
Q2 | $3.18M | Sell |
34,289
-168
| -0.5% | -$16.4K | 1.09% | 24 |
|
|
2018
Q1 | $3.26M | Buy |
34,457
+2,189
| +7% | +$240K | 1.13% | 22 |
|
|
2017
Q4 | $3.12M | Buy |
+32,268
| New | +$3.04M | 1.12% | 26 |
|
Other funds holding ABBV
VCM
VPM
Plimoth Trust's ABBV Position: Q1 2026 in Review
Plimoth Trust reduced its AbbVie (ABBV) stake by 2.4% in Q1 2026, selling an estimated $102K and leaving 18,845 shares worth $4.1M. The position accounts for 0.92% of the portfolio, ranked #36.
Plimoth Trust first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.99M in Q1 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Plimoth Trust held 18,845 shares of AbbVie worth $4.1M as of Q1 2026.
- Plimoth Trust sold 462 AbbVie shares in Q1 2026, an estimated $102K.
- AbbVie made up 0.92% of Plimoth Trust's portfolio in Q1 2026, its #36 holding.
- Plimoth Trust first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- Plimoth Trust's AbbVie position peaked at $4.99M in Q1 2022.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Plimoth Trust's 13F filing for Q1 2026, filed 27 Apr 2026.